Female Osteoporosis
ConditionFemale Osteoporosis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age50-75
SponsorKayseri City Hospital
About this trial
The aim of this study is to compare the Osteoporosis Risk Assessment Tool and the Osteoporosis Self-Assessment Tool with the gold standard DEXA in determining the risk of osteoporosis in the lumbar and femoral regions in female individuals in the Turkish population, and to investigate their sensitivity and specificity in the first stage of screening for the detection of female osteoporosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Postmenopausal women aged 50-75
Patients who underwent imaging with the STRATOS DEXA device at Kayseri City Hospital
Disqualifiers
Patients younger than 50 or older than 75 years of age
Patients with secondary osteoporosis
Male patients
Patients with uncontrolled severe comorbid conditions
Trial population
This study will include female patients aged 50-75 who underwent osteoporosis screening with DEXA at the Kayseri City Hospital FTR outpatient clinics between January 2021 and January 2024.
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
1,500 Participants
are grouped into 1 trial groupGroup A: female osteoporosis group
Trial outcomes
Primary outcomes
1
Dual-energy X-ray absorptiometry (DEXA)
Dual-energy X-ray absorptiometry (DEXA)
Time frame
January 2021 - January 20242
Osteoporosis Self-Assessment Tool (OST)
Osteoporosis Self-Assessment Tool (OST)
Time frame
January 2021 - January 20243
Osteoporosis Risk Assessment Index (ORAI)
Osteoporosis Risk Assessment Index (ORAI)
Time frame
January 2021 - January 2024Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: